Research Article | Open Access
Fereshteh Behmanesh, Hajar Pasha, Ali Asghar Sefidgar, Mohsen Taghizadeh, Ali Akbar Moghadamnia, Hajar Adib Rad, Leyla Shirkhani, "Antifungal Effect of Lavender Essential Oil (Lavandula angustifolia) and Clotrimazole on Candida albicans: An In Vitro Study", Scientifica, vol. 2015, Article ID 261397, 5 pages, 2015. https://doi.org/10.1155/2015/261397
Antifungal Effect of Lavender Essential Oil (Lavandula angustifolia) and Clotrimazole on Candida albicans: An In Vitro Study
Background. The treatment of candidiasis infections is an important problem in the health care system. This study aimed to investigate the in vitro effect of lavender essential oil and clotrimazole on isolated C. albicans from vaginal candidiasis. Materials and Methods. In this clinical trial, C. albicans isolated from the vaginal discharge samples was obtained. Results. The pairwise comparison showed that lavender and clotrimazole had a significant difference; this difference in the lavender group was lower than clotrimazole. But, after 48 hours, there was no difference seen between groups. There was a significant difference between clotrimazole and DMSO groups. Comparing the changes between groups based on the same dilution, at 24 h and 48 h in clotrimazole group, showed a significant difference two times in the fungal cell count that its average during 48 h was less than 24 h. A significant difference was observed between the two periods in lavender group, only at the dilutions of 1/20 and 1/80. The average fungal cell count after 48 h was also lower in lavender group. Conclusions. Given that the lavender has antifungal activity, this can be used as an antifungal agent. However, more clinical studies are necessary to validate its use in candida infection.
Gynecologic infections are the most common reasons women visit a doctor and ask to be treated  and, in recent years, the severity and incidence of fungal infections have increased surprisingly. One of the diseases caused by vaginal endogenous flora is candidiasis. It is estimated that 75% of women experience vulvar-vaginal candidiasis at least once in their lifetime. Almost 45% of women are suffering from this infection twice every year. Fortunately, only a small number of women are suffering from chronic recurrent infections. C. albicans is the responsible germ in 85–90% of vaginal yeast infections . Early diagnosis and appropriate treatment of vaginitis are important, because failure to timely and appropriately treat these infections leads to serious complications such as pelvic inflammatory disease, infertility, chronic pelvic pain, premature birth, and the dangers of HIV infection . Since the number of patients with AIDS and diabetes and the use of antibiotics increase every day and given that this fungal disease has a high prevalence in this patient population, it is important to find a safe and also a proper treatment. Oily essence has traditionally been used in the treatment and the prevention of various diseases and infections .
In the present era, a big trend in medical care in America has occurred which is the use of complementary and alternative medicine. It includes a range of treatments from acupuncture and prayer meetings and, more importantly, the use of herbal medicines which include the traditional herbs and native plants from China, India, Africa, Europe, and America. Although basic scientific research has not been done on these plants, the background of using herbs during the past centuries, as well as being a natural product, has proven that it is a relatively safe therapy. So, this alternative medicine has been emphasized because of the limited side effects and low cost for its application in chronic diseases therapy and prevention .
Lavender (Lavandula angustifolia), as a kind of medicinal herb, can be effectively used in the treatment of vaginal discharges. Lavender essential oil is frequently used in traditional medicine  and its impact on reducing the amount of Candida albicans fungus has been shown in in vitro  and clinical studies .
On the other hand, one of the conventional chemical drugs to treat vaginal candidiasis is clotrimazole. Since this chemical drug has side effects, such as increased liver enzymes, painful urination, and depression (due to systemic absorption of the drug), and complications such as irritation and feeling of tingling or contact dermatitis , and due to the increasing resistance to antifungal drugs , in this study, the effect of lavender (Lavandula angustifolia) and clotrimazole on the vaginal candidiasis growth, in vitro, was assessed.
In this study, sampling was done vaginally in sterile conditions from 45 women with clinical symptoms of vaginal fungal infection who referred to clinics affiliated to Babol University of Medical Sciences. After placing the patient in a lithotomy position and putting a sterile speculum into the vagina, a sterile cotton swab was used for sampling from the posterior fornix and the lateral sides of the vagina, and the sample was then placed in a sterile tube. The samples were tested and delivered to the Mycology Laboratory of Babol University of Medical Sciences. Only 20 out of the 45 samples were positive in in vitro test. The referenced methods used were the cultivation environment of Candida CHROMagar, formed germ tube in human serum, and corn meal agar for making chlamydospore in this environment.
In the laboratory, wet smear was done to detect the yeast fungal cells and trichomonas infections; besides, laboratory culture on Sabouraud, BHI medium for primary isolation of fungi and germ tube test by human blood serum with CHROMagar to identify the types of candida were conducted. The fungi were maintained and passaged in Sabouraud medium for the in vitro evaluation of clotrimazole 1% and the oily essence of lavender on the C. albicans was examined in over 20 samples isolated from 45 patients, using cell count (macrodilution) method. Clotrimazole drop is one of the main drugs that is used to treat fungal infections in Iran and Behvazan Company is one of several pharmaceutical companies in Iran that produces and distributes this drug. Clotrimazole drop was purchased from a pharmacy in Babol, while the lavender essential oil was prepared and purchased from Barij Essence Company. In this company, the aerial parts of lavender plant were used and its essential oil was taken by Clevenger. The compounds of Lavandula angustifolia after GC (Gas Chromatography) were limonene, cineole, linalool, and linalyl acet. It is not clear which one of them has antifungal effect. It seems that the total compounds have antifungal effect.
In macrodilution method, a loopful colony pure culture of C. albicans on Sabouraud dextrose agar provided a 0.5 McF suspension of candidal concentration (10³ and 106 fungal cells per mL) in BHI (Brain Heart Infusion) agar broth culture medium.
After preparing the half-McFarland suspension of the C. albicans, lavender and clotrimazole dilution was performed. Thus, lavender with pure solvent DMSO (Dimethyl Sulfoxide) was diluted to 1/5 in a sterile tube, and the same procedure was also performed for clotrimazole. Then, the dilutions of 1/10, 1/20, 1/40, 1/80, and 1/160 of each drug were prepared and poured in 5 wells of a microplate. In the sixth well of a microplate, the DMSO control was poured and, ultimately, 100 microliters of half-McFarland suspension of fungi was added to all the wells of a microplate. This procedure was performed three times for lavender and three times for clotrimazole (in triplicate) and, finally, the microplates were placed in a bain marie at 37°C. After 24 and 48hrs, the fungal cells were counted using a microscope Neubauer hemocytometer (as red blood cell count in hematology). The clotrimazole drop (1%) was made in Behvazan Pharmaceutical Company and the lavender essential oil was prepared in Barij Essence Company. The obtained data were analyzed using descriptive statistics and the nonparametric analysis Kruskal-Wallis test and Mann-Whitney and Wilcoxon tests were used.
Out of the 45 samples suspected of vaginal candida infection, none of the samples had trichomoniasis in a direct test, but only 25 cases were positive for C. albicans. Due to the failure of the 5 cases, 20 cases of C. albicans obtained from patients were tested in vitro. Analyzing the data, it was found by normality test that the data distribution is not normal. So, the nonparametric Kruskal-Wallis test and Mann-Whitney and Wilcoxon tests were used. The comparison of the three groups of lavender, clotrimazole, and DMSO controls using the Kruskal-Wallis test in the first 24 hours of dilutions 1/40 () and 1/160 () indicated a significant difference between groups. With regard to the other dilutions and after 48h, fungal cell count showed no significant differences between the three groups. The comparison between the two groups of lavender and clotrimazole using Mann-Whitney test showed that the fungal cell count after 24 hours, in dilutions of 1/20 and 1/40 and 1/160, respectively, , , and , had significant difference between the two groups. In these dilutions, during the first 24 hours, cell counts of fungi in lavender group were lower than the clotrimazole group (Figure 1), and, after 48h, no difference was found between the groups (Figure 2). But a comparison of clotrimazole and DMSO groups showed that there is a significant difference between the two groups in dilutions of 1/40 and 1/160 and there is no significant difference between lavender and DMSO. Although, as can be seen in Figure 1, the average fungal cell count in lavender was lower than the other two groups in most dilutions, the tests showed no statistically significant differences.
The Wilcoxon test was performed separately in clotrimazole and lavender groups to compare changes between groups based on the same dilutions between 24h and 48h. The comparison of the clotrimazole group after 24h and 48h showed that there was a significant difference between the fungal cell count for dilutions of 1/10, 1/20, 1/40, 1/80, and 1/160, respectively, , , , , and , and its average in 48h was less than 24h. In the lavender group, a significant difference was observed between the two periods only for dilutions of 1/20 and 1/80 . Also, in this group, the average fungal cell count was also lower after 48h. But, for dilution 1/10, the average fungal cell count after 48h was higher than the more dilutions. Some drugs are more effective at lower dilutions.
With the increase in drug-resistant fungal treatment in recent years and adverse effects of antifungal agents, the need for new drugs has become important. In the present study, it has been shown that the lavender herb has antifungal activity. Studies on the antifungal effects of lavender were different. Lavender had a very weak inhibitory effect of fungus in some studies, but, in most cases, its antifungal effect was significantly positive [11–14]. Devkatte et al.  in a study on herbal oils as potential inhibitors of Candida albicans growth aimed to determine the minimum inhibitory concentration and minimum fungicidal concentration of 38 herbal oil essences. They reported that cinnamon oil was the best and had the impact of the fungicide concentration of 0.03 percent against 4 candida strains. Most oils were located in moderate group and 9 oils were the least effective in which the lavender was considered in the least effective group . Mahboubi et al.  reported that lavender has moderate antifungal activity while other essential oils, such as thyme and geranium, have strong antifungal effects. Mahboubi showed that some essential oils were most effective against candida strains . Basically, lavender oil has a long history of medicinal use in Traditional Chinese Medicine (TCM)  and has antimicrobial activity against fungi and bacteria [12, 19–21]. Several combinations such as linalyl acetate, linalool, butyric acid, and propionic acid are involved in this activity . It was shown in a similar study that the essential oil of Lavandula angustifolia and its main components, linalool and linalyl acetate, can kill or inhibit the growth of fungi . The data showed a significant difference between the three groups of lavender, clotrimazole, and control in higher dilutions (1/40 and 1/160) for antifungal activity. The fungal cell count in lavender group was lower than the other groups. Behmanesh et al. reported that the fungal cell count in tubes containing lavender infusion and lavender essence was lower than clotrimazole tubes. Also, the most effective antifungal effects of drugs (lower fungal cell count) were observed at higher dilutions . In their study, D’Auria et al.  found that higher dilutions of lavender inhibit the formation of fungus and elongation of the fibers and reduce the fungal growth and its diffusion rate in the tissue.
The results of the comparison between the two groups of lavender and clotrimazole showed that fungal cell count after 24h, for dilutions of 1/20 and 1/40 and 1/160, had significant differences. In these dilutions, the fungal cell count in lavender was lower than clotrimazole. In a similar study, it was shown that, in all the different dilutions, clotrimazole had the lowest antifungal effects and the highest fungal cell count. In this study, we found that the infusion of lavender herb and its essence as compared with clotrimazole has a higher antifungal activity against C. albicans .
Data on the comparison of clotrimazole and control groups showed significant differences in concentrations of 1/40 and 1/160 between the two groups. Gharibi et al.  in their study compared the concurrent use of fluconazole and clotrimazole with frequent dose in the treatment of recurrent candidiasis and showed that the two methods for reducing complaints and symptoms of itching, scratching, edema, erythema, and fissures were very effective two weeks after treatment () and the symptoms of vaginal candidiasis also reduced in 6 weeks of treatment in the intervention group and had a significant difference in the control group ().
Research findings about the changes between the groups according to the same dilution but after 24h and 48h in the clotrimazole group showed that, for dilutions of 1/10, 1/20, 1/40, 1/80, and 1/160, there was a significant difference between the two fungal cell counts in which their average was higher in 24h than 48h. Also, in the lavender group, at 1/20 and 1/80 dilutions, a significant difference was observed two times and the average fungal cell count was lower after 48h. Ghahramanlo et al.  conducted a similar survey and demonstrated the antifungal effects increase in acrylic resins with increasing nanoparticle concentration and time compared to contact microorganisms.
According to the results of this study and the information recorded in the old books of medicinal herbs of Iran, we can obtain additional information with further research to support the effectiveness of lavender.
Conflict of Interests
The authors have no conflict of interests.
The authors thank the Deputy of Research and Technology of Babol University of Medical Sciences for the financial support.
- K. G. Rayan, Kistner's Gynecology and Women's Health, Translated by: B. G. Gahani, R. Ghotbi, Golban, Tehran, Iran, 7th edition, 1999.
- J. Breck, Diseases of Women, Translated by: B. G. Gahani, R. Ghotbi, Golban, Tehran, Iran, 15th edition, 2007.
- F. R. Tehrani, M. Farahmand, M. Abedini, and Z. Hashemi, “Prevalence of vaginitis in Iranian women—symptoms and clinical association,” Medical Sciences Journal of Islamic Azad Univesity—Tehran Medical Branch, vol. 22, no. 1, pp. 62–68, 2012.
- J. L. Ríos and M. C. Recio, “Medicinal plants and antimicrobial activity,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 80–84, 2005.
- G. E. Trease and W. C. Evance, Pharmacognosy, Sunders, London, UK, 2000.
- A. Zargari, Herbal Plants, Tehran University Publisher, Tehran, Iran, 6th edition, 1999.
- F. Behmanesh, H. Pasha, A. A. Sefidgar et al., “Comparison of the effect of Lavender and Clotrimazole on the growth of the standard strains of Candida albicans, an in vitro study,” Journal of Babol University of Medical Sciences, vol. 12, no. 2, pp. 26–31, 2010.
- J. Buckle, “Clinical aromatherapy and AIDS,” The Journal of the Association of Nurses in AIDS Care, vol. 13, no. 3, pp. 81–99, 2002.
- R. Khoddam, Generic Drugs of Iran, DIBAJ, Tehran, Iran, 2007.
- E. A. Huff and S. Writer, “Lavender oil is a powerful antifungal that fights skin conditions, Candida,” http://www.naturalnews.com/031470_lavender_oil_antifungal.html.
- A. Zambonelli, A. Zechini D'Aulerio, A. Bianchi, and A. Albasini, “Effects of essential oils on phytopathogenic fungi in vitro,” Journal of Phytopathology, vol. 144, no. 9-10, pp. 491–494, 1996.
- M. L. Estevinho, S. E. T. Afonso, and X. Feás, “Antifungal effect of lavender honey against Candida albicans, Candida krusei and Cryptococcus neoformans,” Journal of Food Science and Technology, vol. 48, no. 5, pp. 640–643, 2011.
- J. V. Larrondo, M. Agut, and M. A. Calvo-Torras, “Antimicrobial activity of essences from labiates,” Microbios, vol. 82, no. 332, pp. 171–172, 1995.
- J. V. Larrondo, M. Agut, and M. A. Calvo, “Effect of essential oils on candida albicans: a scanning electron microscope study,” Biomedical Letters, vol. 48, no. 184, pp. 262–272, 1991.
- A. N. Devkatte, G. B. Zore, and S. M. Karuppayil, “Potential of plant oils as inhibitors of Candida albicans growth,” FEMS Yeast Research, vol. 5, no. 9, pp. 867–873, 2005.
- M. Mahboubi, “Antifungal activity of essential oils from Zataria multiflora, Rosmarinus officinalis, Lavandula stoechas, Artemisia sieberi Besser and Pelargonium graveolens against clinical isolates of Candida albicans,” Pharmacognosy Magazine, vol. 4, no. 15, supplement, pp. 15–18, 2008.
- A. Schwiertz, C. Duttke, J. Hild, and H. J. Müller, “In vitro activity of essential oils on microorganisms isolated from vaginal infections,” International Journal of Aromatherapy, vol. 16, no. 3-4, pp. 169–174, 2006.
- K. Adam, A. Sivropoulou, S. Kokkini, T. Lanaras, and M. Arsenakis, “Antifungal activities of Origanum vulgare subsp.hirtum, Mentha spicata, Lavandula angustifolia, and Salvia fruticosa essential oils against human pathogenic fungi,” Journal of Agricultural and Food Chemistry, vol. 46, no. 5, pp. 1739–1745, 1998.
- C. J. Chu and K. J. Kemper, “Lavender (Lavandula spp). The Longwood Herbal Task Force,” 2001, http://www.longwoodherbal.org/lavender/lavender.pdf.
- H. M. A. Cavanagh and J. M. Wilkinson, “Biological activities of lavender essential oil,” Phytotherapy Research, vol. 16, no. 4, pp. 301–308, 2002.
- N. Morris, “The effects of lavender (Lavendula angustifolium) baths on psychological well-being: two exploratory randomized controls trials,” Complementary Therapies in Medicine, vol. 10, no. 4, pp. 223–228, 2002.
- F. D. D'Auria, M. Tecca, V. Strippoli, G. Salvatore, L. Battinelli, and G. Mazzanti, “Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form,” Medical Mycology, vol. 43, no. 5, pp. 391–396, 2005.
- F. Behmanesh, H. Pasha, A. A. Sefidgar et al., “A comparative study of antifungal activity of Lavender brew, Lavender essential oil, and clotrimazole: an in vitro study,” Caspian Journal of Reproductive Medicine, vol. 1, no. 1, pp. 26–30, 2015.
- T. Gharibi, M. Ganjoo, F. Kamali et al., “Comparison of combined use of fluconazole and clotrimazole with the sequential dose of fluconazole in the treatment of recurrent Candida vaginitis,” Iranian South Medical Journal, vol. 12, no. 1, pp. 34–39, 2009.
- A. Ghahramanlo, O. Rajabi, K. Ghazvini, A. T. Mirmortazavi, and M. M. Haghighi, “Antifungal effect of silver nanoparticles in acrylic resins,” Journal of Mashhad Dental School, vol. 37, no. 3, pp. 239–248, 2013.
Copyright © 2015 Fereshteh Behmanesh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.